There have been few testicular histology reports of adult patients with congenital adrenal hypoplasia/hypogonadal hypogonadism (AHC/HH), but Leydig cell hyperplasia has been observed, an indicator of the possibility of malignant transformation. We aimed to define the basis of AHC/HH in 4 pedigrees of different ethnic backgrounds. One patient was elected to have testicular biopsy which was examined for evidence of carcinoma in situ (CIS). NR0B1 mutation analysis was performed by sequence analysis. NR0B1 expression was investigated by RT-PCR. Testicular biopsy sections were stained with HE or immunostained for OCT3/4, an established marker of CIS. We identified NR0B1 variants in the 4 AHC pedigrees: pedigree 1 (United Arab Emirates), c.1130A>G predicting p.(Glu377Gly); pedigree 2 (English Caucasian), c.327C>A predicting p.(Cys109*); pedigree 3 (Oman), a 6-bp deletion of a direct repeat, c.857_862delTGGTGC predicting p.(Leu286_Val287del); pedigree 4 (English Caucasian), c.1168+1G>A, a regulatory variant within the NR0B1 splice donor site. This last male patient, aged 30 years, presented with evidence of HH but incomplete gonadotrophin deficiency, following an earlier diagnosis of Addison’s disease at 3 years. Hormonal therapy induced virilisation. Testicular biopsy was performed. The c.1168+1G>A variant abrogated normal splicing of testicular mRNA. Histological examination showed poorly organised testicular architecture and absence of spermatozoa. Morphological analyses and the absence of immunohistochemical staining for OCT3/4 excluded the presence of malignant germ cell cancer and its precursor lesion, CIS. These studies add to the knowledge of the types and ethnic diversity of NR0B1 mutations and their associated phenotypes, and provide insight into the assessment and interpretation of testicular histology in AHC and HH.

1.
Achermann JC: The role of SF1/DAX1 in adrenal and reproductive function. Ann Endocrinol 66:233–239 (2005).
2.
Achermann JC, Ito M, Silverman BL, Habiby RL, Pang S, et al: Missense mutations cluster within the carboxyl-terminal region of DAX-1 and impair transcriptional repression. J Clin Endocrinol Metab 86:3171–3175 (2001).
3.
Brown P, Scobie GA, Townsend J, Bayne RA, Seckl JR, et al: Identification of a novel missense mutation that is as damaging to DAX-1 repressor function as a nonsense mutation. J Clin Endocrinol Metab 88:1341–1349 (2003).
4.
de Jong J, Stoop H, Dohle GR, Bangma CH, Kliffen M, et al: Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours. J Pathol 206:242–249 (2005).
5.
Franzese A, Brunetti-Pierri N, Spagnuolo MI, Spadaro R, Giugliano M, et al: Inappropriate tall stature and renal ectopy in a male patient with X-linked congenital adrenal hypoplasia due to a novel missense mutation in the DAX-1 gene. Am J Med Genet A 135:72–74 (2005).
6.
Frapsauce C, Ravel C, Legendre M, Sibony M, Mandelbaum J, et al: Birth after TESE-ICSI in a man with hypogonadotropic hypogonadism and congenital adrenal hypoplasia linked to a DAX-1 (NR0B1) mutation. Hum Reprod 26:724–728 (2011).
7.
Goto M, Katsumata N: X-linked adrenal hypoplasia congenita caused by a novel intronic mutation of the DAX-1 gene. Horm Res 71:120–124 (2009).
8.
Jadhav U, Harris RM, Jameson JL: Hypogonadotropic hypogonadism in subjects with DAX1 mutations. Mol Cell Endocrinol 346:65–73 (2011).
9.
Kelly VR, Xu B, Kuick R, Koenig RJ, Hammer GD: Dax1 up-regulates Oct4 expression in mouse embryonic stem cells via LRH-1 and SRA. Mol Endocrinol 24:2281–2291 (2010).
10.
Landau Z, Hanukoglu A, Sack J, Goldstein N, Weintrob N, et al: Clinical and genetic heterogeneity of congenital adrenal hypoplasia due to NR0B1 gene mutations. Clin Endocrinol 72:448–454 (2010).
11.
Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, et al: POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 63:2244–2250 (2003).
12.
Monaco AP, Walker AP, Millwood I, Larin Z, Lehrach H: A yeast artificial chromosome contig containing the complete Duchenne muscular dystrophy gene. Genomics 12:465–473 (1992).
13.
Morii M, Takahashi T, Takahashi I, Komatsu K, Sagishima M, et al: X-linked adrenal hypoplasia congenita: testicular histology before puberty. Pediatr Int 49:526–529 (2007).
14.
Muscatelli F, Strom TM, Walker AP, Zanaria E, Recan D, et al: Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 372:672–676 (1994).
15.
Oosterhuis JW, Looijenga LH: Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5:210–222 (2005).
16.
Ozisik G, Mantovani G, Achermann JC, Persani L, Spada A, et al: An alternate translation initiation site circumvents an amino-terminal DAX1 nonsense mutation leading to a mild form of X-linked adrenal hypoplasia congenita. J Clin Endocrinol Metab 88:417–423 (2003).
17.
Phelan JK, McCabe ER: Mutations in NR0B1 (DAX1) and NR5A1 (SF1) responsible for adrenal hypoplasia congenita. Hum Mutat 18:472–487 (2001).
18.
Seminara SB, Achermann JC, Genel M, Jameson JL, Crowley WF Jr: X-linked adrenal hypoplasia congenita: a mutation in DAX1 expands the phenotypic spectrum in males and females. J Clin Endocrinol Metab 84:4501–4509 (1999).
19.
Skinningsrud B, Husebye ES, Gilfillan GD, Frengen E, Erichsen A, et al: X-linked congenital adrenal hypoplasia with hypogonadotropic hypogonadism caused by an inversion disrupting a conserved noncoding element upstream of the NR0B1 (DAX1) gene. J Clin Endocrinol Metab 94:4086–4093 (2009).
20.
Sonne SB, Kristensen DM, Novotny GW, Olesen IA, Nielsen JE, et al: Testicular dysgenesis syndrome and the origin of carcinoma in situ testis. Int J Androl 31:275–287 (2008).
21.
The 1000 Genomes Project Consortium: A map of human genome variation from population-scale sequencing. Nature 467:1061–1073 (2010).
22.
van Casteren NJ, Stoop H, Dohle GR, de Wit R, Oosterhuis JW, Looijenga LH: Noninvasive detection of testicular carcinoma in situ in semen using OCT3/4. Eur Urol 54:153–158 (2008).
23.
Walker AP, Chelly J, Love DR, Brush YI, Recan D, et al: A YAC contig in Xp21 containing the adrenal hypoplasia congenita and glycerol kinase deficiency genes. Hum Mol Genet 1:579–585 (1992).
24.
Zanaria E, Muscatelli F, Bardoni B, Strom TM, Guioli S, et al: An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 372:635–641 (1994).
25.
Zhang YH, Guo W, Wagner RL, Huang BL, McCabe L, et al: DAX1 mutations map to putative structural domains in a deduced three-dimensional model. Am J Hum Genet 62:855–864 (1998).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.